<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Caspase-independent cell <z:hpo ids='HP_0011420'>death</z:hpo> may have a critical role to play in the therapeutic destruction of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently it has been suggested that one of the mechanisms by which rituximab, a therapeutic anti-CD20 antibody, kills B cells is caspase-independent </plain></SENT>
<SENT sid="2" pm="."><plain>In this study we show that rituximab can induce <z:hpo ids='HP_0011420'>death</z:hpo> in a variety of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> derived cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Rituximab-treated cells show leakage of adenylate kinase, surface expression of phosphatidylserine, upregulation of the cellular stress protein HSP70, phosphorylation of the survival protein Akt, and depolarisation of the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> membrane but no loss of <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> or <z:mpath ids='MPATH_3'>apoptosis</z:mpath> inducing factor </plain></SENT>
<SENT sid="4" pm="."><plain>Caspase inhibitors do not block these events </plain></SENT>
<SENT sid="5" pm="."><plain>In support of these data there is no cleavage of caspases 3, 8 and 9, poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase, <z:chebi fb="0" ids="30153">BH3</z:chebi> interacting domain <z:hpo ids='HP_0011420'>death</z:hpo> <z:chebi fb="4" ids="48705">agonist</z:chebi> or genomic DNA </plain></SENT>
<SENT sid="6" pm="."><plain>Morphologically, cells show nuclear enlargement and cytoplasmic vacuolisation </plain></SENT>
<SENT sid="7" pm="."><plain>Triggering of receptor mediated <z:hpo ids='HP_0011420'>death</z:hpo> in CD95 responsive lines results in "classical" <z:mpath ids='MPATH_3'>apoptosis</z:mpath> indicating that the internal machinery necessary for <z:mpath ids='MPATH_3'>apoptosis</z:mpath> is intact in these lines </plain></SENT>
<SENT sid="8" pm="."><plain>The results suggest that rituximab can kill human B cells via a caspase-independent form of programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> that shares features of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>This pathway may be relevant to the clinical efficacy of rituximab </plain></SENT>
</text></document>